Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ASP-1012 by KaliVir Immunotherapeutics for Metastatic Ovarian Cancer: Likelihood of Approval
ASP-1012 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData,...
ASP-1012 by KaliVir Immunotherapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
ASP-1012 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
ASP-1012 by KaliVir Immunotherapeutics for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
ASP-1012 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to...
ASP-1012 by KaliVir Immunotherapeutics for Metastatic Melanoma: Likelihood of Approval
ASP-1012 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase...
ASP-1012 by KaliVir Immunotherapeutics for Gastric Cancer: Likelihood of Approval
ASP-1012 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...